Blauvelt, A., Papp, K., Gottlieb, A., Jarell, A., Reich, K., Maari, C., Gordon, K., Ferris, L., Langley, R., Tada, Y., Lima, R., Elmaraghy, H., Gallo, G., Renda, L., Park, S., Burge, R., Bagel, J., & , (2020). a head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial. British journal of dermatology, 182, 1348–1358. http://access.bl.uk/ark:/81055/vdc_100103792231.0x000061